H2020 FET projects in biotechnologies

Friday, 29 January, 2016
EU-funded projects under FET advancing the state of the art and applications for biotechnologies.

AMECRYS aims at revolutionising the manufacture of biopharmaceuticals with innovative membrane crystallization technology. A new Continuous Template-Assisted Membrane Crystallizer is aiming for unprecedented purification and separation of proteins resulting in a much more efficient manufacturing process.

FutureAgriculture proposes an efficient metabolic bypass for photorespiration in plants which leads to the loss of CO2 and consequently to reduced growth yield. Using new enzyme based synthetic pathways to bypass photorespiration has the potential to significantly increase the photosynthetic efficiency, supporting higher yields of crop, a pressing need for a continually growing world population.

Human Brain Project (HBP): the goal of the Human Brain Flagship Project is to  put in place a cutting-edge ICT-based scientific research infrastructure, that will permit scientific and industrial researchers to advance our knowledge in the fields of neuroscience, computing and brain-related medicine.

Mara will develop cost-effective, autonomous DNA sensors and “DNA origami”-based molecular robots for the detection and destruction of cells. Multidrug resistant bacterial pathogens will be used as model system for the first proof-of-concept because alternative treatments of infectious diseases are essential to contain their further spread.

MGR-Grammar's goal is to leverage Synthetic Biology with cutting-edge DNA synthesis technologies and high-throughput analysis to generate new types of biological datasets that systematically explore all possible regulatory landscapes rather than just the naturally occurring regulatory sequences.  The expectation is to make a significant breakthrough in deciphering and evolving the regulatory code.

PROSEQO envisages novel technologies which will substantially advance protein and DNA sequencing. This might eventually radically transform patient treatment, enabling precise monitoring of disease response to therapeutics at the molecular level.

RECORD-IT seeks to develop an intelligent biocompatible sensing device which detects complex behavioral changes in ion concentrations.  The sensor will use wet NOMFETs, coated Si nanowires, self-conjugated polymers, arrays of photocells, flow of lipids. The proposed approach will be based on reservoir computing.

SYMBIOTIC seeks to develop an autonomous electrochemical biosensor that is lightweight, disposable and of low cost by using an outstanding innovative approach: hosting synergistically the bio-receptor element inside a passive direct methanol fuel cell (DMFC). The proposed electrochemical biosensor will be completely autonomous operating at room temperature and using the oxygen present in the air, thereby allowing diagnosis everywhere.